TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nixonnoxin AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
698
|
459
|
545 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
559
|
289
|
500 |
| EBITDA |
503
|
241
|
500 |
| Total assets |
3,359
|
3,009
|
2,858 |
| Current assets |
1,960
|
2,101
|
1,954 |
| Current liabilities |
129
|
70
|
82 |
| Equity capital |
3,072
|
2,789
|
2,637 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.5%
|
92.7%
|
92.3% |
| Turnover per employee |
349
|
230
|
272 |
| Profit as a percentage of turnover |
80.1%
|
63.0%
|
91.7% |
| Return on assets (ROA) |
16.6%
|
9.6%
|
17.5% |
| Current ratio |
1519.4%
|
3001.4%
|
2382.9% |
| Return on equity (ROE) |
18.2%
|
10.4%
|
19.0% |
| Change turnover |
255
|
-87
|
94 |
| Change turnover % |
57%
|
-16%
|
21% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.